Earnings Summary: Highlights of Organon’s Q2 2023 results

Earnings Summary: Highlights of Organon’s Q2 2023 results

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter…

Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim…

Four factors that do not work in favor of Beyond Meat (BYND)

Shares of Beyond Meat, Inc. (NASDAQ: BYND) stayed red on Wednesday. The stock has dropped 64% over the past 12…

Earnings Summary: Jacobs Solutions reports higher Q3 2023 revenues

Jacobs Solutions Inc. (NYSE: J), a leading provider of technical professional services, reported an increase in third-quarter revenues. The company…

Earnings Summary: A snapshot of Expeditors International’s Q2 results

Expeditors International of Washington, Inc. (NASDAQ: EXPD) announced financial results for the second quarter of 2023. The logistics company said…

Walt Disney Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript

Entertainment giant The Walt Disney Company (NYSE: DIS) will be reporting operating results for the third quarter of 2023 today…

Earnings Summary: Charles River Laboratories reports Q2 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.…

Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the…

Twilio (TWLO) Earnings: 2Q23 Key Numbers

Twilio (NYSE: TWLO) reported total revenue of $1.04 billion for the second quarter of 2023, which was up 10% year-over-year.…

Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and…